Clinical Trial Update: A Study of LY3076226 in Participants With Advanced or Metastatic Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial update for LY3076226 in advanced or metastatic cancer; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• LY3076226

Snippet

Sponsor: Eli Lilly and Company | Conditions: Advanced Cancer, Metastatic Cancer | Phase 1 | Status: COMPLETED | Results posted: 2020-04-17